Global Immuno-oncology Drugs Market Overview
The global Immuno-oncology Drugs market is expected to reach USD XX Million by the end of year 2027 from USD XX Million from the year 2021. In the span of last two years, Immuno-oncology Drugs market has shown promising growth from both sides (Demand and Supply) and demand from end users is expected to rise continuously. It has also been observed that the Immuno-oncology Drugs market has registered XX% of growth rate during 2016-2021 and is estimated to register XX% of CAGR during the period 2021 to 2027.
COVID 19 Impact on Immuno-oncology Drugs Market
The COVID19 outbreak had a major impact on several industries on different levels; Some of these were border restrictions, transportation, and logistics restrictions, and worldwide bans. It also created economic uncertainty as the outbreak created a situation where both manufacturing and service industries were kept shut for very long period. Lack of availability of solution and the growing number of people infected with COVID and the uncertainty about the end of the crisis are much greater than with previous outbreaks. The pandemic has resulted in the closure of regions, border restrictions and the breakdown of transport networks.
Segment Analysis of Immuno-oncology Drugs Market
This study on Immuno-oncology Drugs market estimates and provides revenue growth at global, regional and country levels also, offers an overview of the latest developments in each of the sub-sectors from 2016 to 2027. For this analysis, READ Market Research has bifurcated the market of Immuno-oncology Drugs into Type Segment, Application Segment and Regional Segment.
The companies mentioned in the report are:
Amgen Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Note: We can also add companies which are not part of the above list
One of the very important chapter of Immuno-oncology Drugs market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
Global Immuno-oncology Drugs Market Analysis By Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
In the year 2021, Immune Checkpoint Inhibitors segment had XX% of market share and in terms of value, the Immune Checkpoint Inhibitors market was valued at USD XX Million. It is expected that Immune Checkpoint Inhibitors will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global Immuno-oncology Drugs Market Analysis By Application
Hospitals
Pharmacies
Online Pharmacies
Hospitals segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2021. The Hospitals segment is expected to grow at USD XX million by the end of year 2027.
Regional Analysis
Geographically, the global Immuno-oncology Drugs market has been categorized as North America, Europe, the Asia-Pacific, the Middle East & Africa, and South America. North America accounted Immuno-oncology Drugs market accounted for XX% of the market share in the year 2021 and register strong growth during the forecast period. However, the APAC area is experiencing significant growth due to various factors.
Report Scope:
Market Size: XX Million (Ask for Sample in order to view the details)
CAGR: XX% Ask for Sample in order to view the details)
Base Year: 2021
Forecast Period: 2022-2027
Forecast Units: Value (USD Million)
Geographies Covered: North America, Europe, Asia-Pacific, Middle East & Africa, South America
Frequently Asked Questions - FAQ:
What will be the dynamics for the adoption of Immuno-oncology Drugs market based on Healthcare Industry
Which product will contribute more to the overall market share by 2027
Which region is expected to adopt Immuno-oncology Drugs offerings at a fast rate
What are the key market dynamics influencing Immuno-oncology Drugs market growth How will they turn into strengths or weaknesses of companies operating in the market space
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type (2022-2027)
1.3.2 Immune Checkpoint Inhibitors
1.3.3 Monoclonal Antibodies
1.3.4 Cytokine-Based Immunotherapy
1.3.5 Cancer Vaccines
1.3.6 CAR-T Cell Therapy
1.4 Market Segment by Application
1.4.1 Global Immuno-oncology Drugs Market Share by Application (2022-2027)
1.4.2 Hospitals
1.4.3 Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-oncology Drugs Market Size
2.1.1 Global Immuno-oncology Drugs Revenue 2016-2027
2.1.2 Global Immuno-oncology Drugs Sales 2016-2027
2.2 Immuno-oncology Drugs Growth Rate by Regions
2.2.1 Global Immuno-oncology Drugs Sales by Regions 2016-2021
2.2.2 Global Immuno-oncology Drugs Revenue by Regions 2016-2021
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Immuno-oncology Drugs Sales by Manufacturers
3.1.1 Immuno-oncology Drugs Sales by Manufacturers 2016-2021
3.1.2 Immuno-oncology Drugs Sales Market Share by Manufacturers 2016-2021
3.2 Revenue by Manufacturers
3.2.1 Immuno-oncology Drugs Revenue by Manufacturers (2016-2021)
3.2.2 Immuno-oncology Drugs Revenue Share by Manufacturers (2016-2021)
3.2.3 Global Immuno-oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Immuno-oncology Drugs Price by Manufacturers
3.4 Key Manufacturers Immuno-oncology Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
3.6 Key Manufacturers Immuno-oncology Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Immune Checkpoint Inhibitors Sales and Revenue (2016-2021)
4.1.2 Monoclonal Antibodies Sales and Revenue (2016-2021)
4.1.3 Cytokine-Based Immunotherapy Sales and Revenue (2016-2021)
4.1.4 Cancer Vaccines Sales and Revenue (2016-2021)
4.1.5 CAR-T Cell Therapy Sales and Revenue (2016-2021)
4.2 Global Immuno-oncology Drugs Sales Market Share by Type
4.3 Global Immuno-oncology Drugs Revenue Market Share by Type
4.4 Immuno-oncology Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Immuno-oncology Drugs Sales by Application
6 United States
6.1 United States Immuno-oncology Drugs Breakdown Data by Company
6.2 United States Immuno-oncology Drugs Breakdown Data by Type
6.3 United States Immuno-oncology Drugs Breakdown Data by Application
7 European Union
7.1 European Union Immuno-oncology Drugs Breakdown Data by Company
7.2 European Union Immuno-oncology Drugs Breakdown Data by Type
7.3 European Union Immuno-oncology Drugs Breakdown Data by Application
8 China
8.1 China Immuno-oncology Drugs Breakdown Data by Company
8.2 China Immuno-oncology Drugs Breakdown Data by Type
8.3 China Immuno-oncology Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Immuno-oncology Drugs Breakdown Data by Company
9.2 Rest of World Immuno-oncology Drugs Breakdown Data by Type
9.3 Rest of World Immuno-oncology Drugs Breakdown Data by Application
9.4 Rest of World Immuno-oncology Drugs Breakdown Data by Countries
9.4.1 Rest of World Immuno-oncology Drugs Sales by Countries
9.4.2 Rest of World Immuno-oncology Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Amgen, Inc
10.1.1 Amgen, Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.1.4 Immuno-oncology Drugs Product Introduction
10.1.5 Amgen, Inc Recent Development
10.2 AstraZeneca, Plc
10.2.1 AstraZeneca, Plc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.2.4 Immuno-oncology Drugs Product Introduction
10.2.5 AstraZeneca, Plc Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.3.4 Immuno-oncology Drugs Product Introduction
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Celgene Corporation
10.4.1 Celgene Corporation Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.4.4 Immuno-oncology Drugs Product Introduction
10.4.5 Celgene Corporation Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.5.4 Immuno-oncology Drugs Product Introduction
10.5.5 Eli Lilly and Company Recent Development
10.6 Merck & Co.
10.6.1 Merck & Co. Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.6.4 Immuno-oncology Drugs Product Introduction
10.6.5 Merck & Co. Recent Development
10.7 Hoffmann-La Roche AG
10.7.1 Hoffmann-La Roche AG Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.7.4 Immuno-oncology Drugs Product Introduction
10.7.5 Hoffmann-La Roche AG Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.8.4 Immuno-oncology Drugs Product Introduction
10.8.5 Johnson & Johnson Recent Development
10.9 Novartis International AG
10.9.1 Novartis International AG Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.9.4 Immuno-oncology Drugs Product Introduction
10.9.5 Novartis International AG Recent Development
10.10 AbbVie, Inc.
10.10.1 AbbVie, Inc. Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
10.10.4 Immuno-oncology Drugs Product Introduction
10.10.5 AbbVie, Inc. Recent Development
10.11 Pfizer Inc.
10.12 Sanofi S.A.
10.13 EMD Serono, Inc.
10.14 Gilead Sciences Inc.
10.15 Prometheus Therapeutics & Diagnostics
10.16 Aduro BioTech
10.17 Galena Biopharma
10.18 Bavarian Nordic
10.19 Celldex Therapeutics
10.20 ImmunoCellular Therapeutics
10.21 Incyte
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Immuno-oncology Drugs Sales Channels
11.2.2 Immuno-oncology Drugs Distributors
11.3 Immuno-oncology Drugs Customers
12 Market Forecast
12.1 Global Immuno-oncology Drugs Sales and Revenue Forecast 2022-2027
12.2 Global Immuno-oncology Drugs Sales Forecast by Type
12.3 Global Immuno-oncology Drugs Sales Forecast by Application
12.4 Immuno-oncology Drugs Forecast by Regions
12.4.1 Global Immuno-oncology Drugs Sales Forecast by Regions 2022-2027
12.4.2 Global Immuno-oncology Drugs Revenue Forecast by Regions 2022-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Disclaimer
List of Tables and Figures
Figure Immuno-oncology Drugs Product Picture
Table Immuno-oncology Drugs Key Market Segments
Table Major Manufacturers Immuno-oncology Drugs Covered in This Report
Table Global Immuno-oncology Drugs Market Size Growth Rate by Type 2022-2027 (K Units) & (Million US$)
Figure Global Immuno-oncology Drugs Sales Market Shar by Type 2016-2027
Figure Immune Checkpoint Inhibitors Figures
Table Major Manufacturers of Immune Checkpoint Inhibitors
Figure Monoclonal Antibodies Figures
Table Major Manufacturers of Monoclonal Antibodies
Figure Cytokine-Based Immunotherapy Figures
Table Major Manufacturers of Cytokine-Based Immunotherapy
Figure Cancer Vaccines Figures
Table Major Manufacturers of Cancer Vaccines
Figure CAR-T Cell Therapy Figures
Table Major Manufacturers of CAR-T Cell Therapy
Table Global Immuno-oncology Drugs Market Share by Application 2022-2027 (K Units)
Figure Hospitals Use Case
Figure Pharmacies Use Case
Figure Online Pharmacies Use Case
Figure Immuno-oncology Drugs Report Years Considered
Figure Global Immuno-oncology Drugs Market Size 2016-2027 (Million US$)
Figure Global Immuno-oncology Drugs Sales 2016-2021 (K Units)
Table Global Immuno-oncology Drugs Market Size by Regions 2016-2021 (K Units) & (Million US$)
Table Global Immuno-oncology Drugs Sales by Regions 2016-2021 (K Units)
Table Global Immuno-oncology Drugs Sales Market Share by Regions 2016-2021
Figure Global Immuno-oncology Drugs Sales Market Share by Regions 2016-2021
Figure Global Immuno-oncology Drugs Sales Market Share by Regions in 2021
Table Global Immuno-oncology Drugs Revenue by Regions 2016-2021 (Million US$)
Table Global Immuno-oncology Drugs Revenue Market Share by Regions 2016-2021
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions 2016-2021
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2021
Table Market Top Trends
Table Global Immuno-oncology Drugs Sales by Manufacturers (2016-2021) (K Units)
Table Global Immuno-oncology Drugs Sales Share by Manufacturers (2016-2021)
Figure Global Immuno-oncology Drugs Sales Share by Manufacturers in 2021
Table Immuno-oncology Drugs Revenue by Manufacturers (2016-2021) (Million USD)
Table Immuno-oncology Drugs Revenue Share by Manufacturers (2016-2021)
Figure Immuno-oncology Drugs Value Share by Manufacturers in 2021
Table Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Immuno-oncology Drugs Price (2016-2021) (USD/Unit)
Table Key Manufacturers Immuno-oncology Drugs Plants/Factories Distribution
Table Key Manufacturers Immuno-oncology Drugs Area Served
Table Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
Table Key Manufacturers Immuno-oncology Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune Checkpoint Inhibitors Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Monoclonal Antibodies Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Cytokine-Based Immunotherapy Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Cancer Vaccines Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global CAR-T Cell Therapy Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Immuno-oncology Drugs Sales by Type (2016-2021) (K Units)
Table Global Immuno-oncology Drugs Sales Share by Type (2016-2021)
Figure Global Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Figure Global Immuno-oncology Drugs Sales Market Share by Type in 2021
Table Global Immuno-oncology Drugs Revenue by Type (2016-2021) (Million US$)
Table Global Immuno-oncology Drugs Revenue Share by Type (2016-2021)
Figure Global Immuno-oncology Drugs Revenue Market Share by Type (2016-2021)
Figure Global Immuno-oncology Drugs Revenue Market Share by Type in 2021
Table Immuno-oncology Drugs Price by Type 2016-2021 (USD/Unit)
Table Global Immuno-oncology Drugs Sales by Application (2016-2021) (K Units)
Table Global Immuno-oncology Drugs Sales Share by Application (2016-2021)
Figure Global Sales Immuno-oncology Drugs Market Share by Application (2016-2021)
Figure Global Sales Immuno-oncology Drugs Market Share by Application (2016-2021)
Figure United States Immuno-oncology Drugs Sales Growth Rate 2016-2021 (K Units)
Figure United States Immuno-oncology Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table United States Immuno-oncology Drugs Sales by Company (2016-2021) (K Units)
Table United States Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Figure United States Immuno-oncology Drugs Sales Market Share by Company in 2021
Table United States Immuno-oncology Drugs Sales by Type (2016-2021) (K Units)
Table United States Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Figure United States Immuno-oncology Drugs Market Share by Type in 2021
Table United States Immuno-oncology Drugs Sales by Application (2016-2021) (K Units)
Table United States Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Figure United States Immuno-oncology Drugs Market Share by Application in 2021
Figure European Union Immuno-oncology Drugs Sales Growth Rate 2016-2021 (K Units)
Figure European Union Immuno-oncology Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table European Union Immuno-oncology Drugs Sales by Company (2016-2021) (K Units)
Table European Union Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Figure European Union Immuno-oncology Drugs Sales Market Share by Company in 2021
Table European Union Immuno-oncology Drugs Sales by Type (2016-2021) (K Units)
Table European Union Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Figure European Union Immuno-oncology Drugs Market Share by Type
Table European Union Immuno-oncology Drugs Sales by Application (2016-2021) (K Units)
Table European Union Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Figure European Union Immuno-oncology Drugs Market Share by Application
Figure China Immuno-oncology Drugs Sales Growth Rate 2016-2021 (K Units)
Figure China Immuno-oncology Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table China Immuno-oncology Drugs Sales by Company (2016-2021) (K Units)
Table China Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Figure China Immuno-oncology Drugs Sales Market Share by Company in 2021
Table China Immuno-oncology Drugs Sales by Type (2016-2021) (K Units)
Table China Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Figure China Immuno-oncology Drugs Market Share by Type in 2021
Table China Immuno-oncology Drugs Sales by Application (2016-2021) (K Units)
Table China Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Figure China Immuno-oncology Drugs Market Share by Application in 2021
Figure Rest of World Immuno-oncology Drugs Sales Growth Rate 2016-2021 (K Units)
Figure Rest of World Immuno-oncology Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table Rest of World Immuno-oncology Drugs Sales by Company (2016-2021) (K Units)
Table Rest of World Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Figure Rest of World Immuno-oncology Drugs Sales Market Share by Company in 2021
Table Rest of World Immuno-oncology Drugs Sales by Type (2016-2021) (K Units)
Table Rest of World Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Figure Rest of World Immuno-oncology Drugs Market Share by Type in 2021
Table Rest of World Immuno-oncology Drugs Sales by Application (2016-2021) (K Units)
Table Rest of World Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Figure Rest of World Immuno-oncology Drugs Market Share by Application in 2021
Table Rest of World Immuno-oncology Drugs Sales by Countries (2016-2021) (K Units)
Table Rest of World Immuno-oncology Drugs Sales Market Share by Countries (2016-2021)
Figure Rest of World Immuno-oncology Drugs Sales Market Share by Countries in 2021
Table Rest of World Immuno-oncology Drugs Revenue by Countries (2016-2021) (Million US$)
Table Rest of World Immuno-oncology Drugs Revenue Market Share by Countries (2016-2021)
Figure Rest of World Immuno-oncology Drugs Revenue Market Share by Countries in 2021
Figure Japan Immuno-oncology Drugs Sales Growth Rate (2016-2021) (K Units)
Figure Japan Immuno-oncology Drugs Revenue Growth Rate (2016-2021) (K Units)
Figure Korea Immuno-oncology Drugs Sales Growth Rate (2016-2021) (K Units)
Figure Korea Immuno-oncology Drugs Revenue Growth Rate (2016-2021) (K Units)
Figure India Immuno-oncology Drugs Sales Growth Rate (2016-2021) (K Units)
Figure India Immuno-oncology Drugs Revenue Growth Rate (2016-2021) (K Units)
Figure Southeast Asia Immuno-oncology Drugs Sales Growth Rate (2016-2021) (K Units)
Figure Southeast Asia Immuno-oncology Drugs Revenue Growth Rate (2016-2021) (K Units)
Table Amgen, Inc Company Details
Table Amgen, Inc Description and Business Overview
Table Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Amgen, Inc Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Amgen, Inc Immuno-oncology Drugs Sales Market Share in Global Market
Table Amgen, Inc Recent Development
Table AstraZeneca, Plc Company Details
Table AstraZeneca, Plc Description and Business Overview
Table AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table AstraZeneca, Plc Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table AstraZeneca, Plc Immuno-oncology Drugs Sales Market Share in Global Market
Table AstraZeneca, Plc Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Description and Business Overview
Table Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Celgene Corporation Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Celgene Corporation Immuno-oncology Drugs Sales Market Share in Global Market
Table Celgene Corporation Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Eli Lilly and Company Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Eli Lilly and Company Immuno-oncology Drugs Sales Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Description and Business Overview
Table Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Merck & Co. Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Merck & Co. Immuno-oncology Drugs Sales Market Share in Global Market
Table Merck & Co. Recent Development
Table Hoffmann-La Roche AG Company Details
Table Hoffmann-La Roche AG Description and Business Overview
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales Market Share in Global Market
Table Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Johnson & Johnson Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Johnson & Johnson Immuno-oncology Drugs Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Description and Business Overview
Table Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Novartis International AG Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table Novartis International AG Immuno-oncology Drugs Sales Market Share in Global Market
Table Novartis International AG Recent Development
Table AbbVie, Inc. Company Details
Table AbbVie, Inc. Description and Business Overview
Table AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table AbbVie, Inc. Immuno-oncology Drugs Sales Growth Rate (2016-2021)
Table AbbVie, Inc. Immuno-oncology Drugs Sales Market Share in Global Market
Table AbbVie, Inc. Recent Development
Table Pfizer Inc. Company Details
Table Sanofi S.A. Company Details
Table EMD Serono, Inc. Company Details
Table Gilead Sciences Inc. Company Details
Table Prometheus Therapeutics & Diagnostics Company Details
Table Aduro BioTech Company Details
Table Galena Biopharma Company Details
Table Bavarian Nordic Company Details
Table Celldex Therapeutics Company Details
Table ImmunoCellular Therapeutics Company Details
Table Incyte Company Details
Figure Immuno-oncology Drugs Value Chain
Table Immuno-oncology Drugs Distributors List
Table Immuno-oncology Drugs Customers List
Table Global Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units) & (Million US$)
Figure Global Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Table Global Immuno-oncology Drugs Sales Forecast by Type 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Sales Forecast by Type 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Sales Market Share Forecast by Type 2022-2027
Table Global Immuno-oncology Drugs Sales Forecast by Application 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Sales Forecast by Application 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Sales Market Share Forecast by Application 2022-2027
Table Global Immuno-oncology Drugs Sales Forecast by Regions 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Sales Forecast by Regions 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Sales Market Share Forecast by Regions 2022-2027
Table Global Immuno-oncology Drugs Revenue Forecast by Regions 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Revenue Forecast by Regions 2022-2027 (K Units)
Figure Global Immuno-oncology Drugs Revenue Market Share Forecast by Regions 2022-2027
Figure United States Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure United States Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Figure European Union Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure European Union Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Figure China Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure China Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Figure Japan Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure Japan Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Figure Korea Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure Korea Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Figure India Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure India Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Figure Southeast Asia Immuno-oncology Drugs Sales Forecast 2022-2027 (K Units)
Figure Southeast Asia Immuno-oncology Drugs Revenue Forecast 2022-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources